The Minister for Health, Wicklow TD, Simon Harris says he has been assured that there will be no delay in accessing the drug Spinraza, following a lengthy campaign by parents of those affected.
The HSE’s leadership team has approved access to the drug for children with type 1, 2 and 3 Spinal Muscular Atrophy on an exceptional and individualised basis.
Earlier this year, the HSE said the drug would cost about €600,000 in the first year to treat each of the 25 Irish children with the disease and €380,000 a year thereafter,.
Spinraza is now approved in 26 countries around Europe with just Estonia rejecting it.
Tailteann Titans Wicklow Look Forward To Louth After Championship 2027 Draw
HIQA Finds Safety Improvements For Residents In Shillelagh Home
Arklow Nurse Is Named Hibernia College Student Of The Year
Hollywood Actor Kevin Bacon Takes In The Raw Splendour Of County Wicklow
Retained Firefighters Could Serve Until 66 Under Bill Proposed By Wicklow TD